Publication | Open Access

Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design

Regenerative MedicineCell TherapyHeart FailureBone Marrow FailureCardiovascular DiseaseMyocardial InfarctionStem CellsHematologyImmunologyFirst Mononuclear CellsIntramyocardial InjectionAutologous Bone MarrowStem-cell TherapyMedicineCell TransplantationCardiologyHealth Sciences